# Metabolism, Excretion, and Mass Balance Study of Quemliclustat in Healthy Adult Participants (ARC-24)

> **NCT07364214** · PHASE1 · COMPLETED · sponsor: **Arcus Biosciences, Inc.** · enrollment: 8 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** Quemliclustat

## Key facts

- **NCT ID:** NCT07364214
- **Lead sponsor:** Arcus Biosciences, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2026-02-03
- **Primary completion:** 2026-04-06
- **Final completion:** 2026-04-06
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2026-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07364214

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07364214, "Metabolism, Excretion, and Mass Balance Study of Quemliclustat in Healthy Adult Participants (ARC-24)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT07364214. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*